ANDREW HUBERMAN: It is shocking how many young people are taking nicotine
Takes 90 seconds Private Always free GLP-1 weight care with compounded semaglutide, reviewed by a licensed provider and fulfilled through a state-licensed compounding pharmacy
GLP-1 Medications: Work with natural hunger hormones Multiple complementary mechanisms Target biological causes of overeating Produce 10-22% average weight loss Much more effective than traditional options Medical Uses: FDA-Approved Indications: For Type 2 Diabetes: All GLP-1 medications originally approved for diabetes Improve blood sugar control Reduce A1C by 1-2 percentage points Lower risk of cardiovascular events For Chronic Weight Management: Semaglutide (Wegovy): Approved 2021 Tirzepatide (Zepbound): Approved 2023 Liraglutide (Saxenda): Approved 2014 Requirements for weight loss approval: BMI 30, or BMI 27 with weight-related condition (diabetes, hypertension, sleep apnea, etc.) Off-Label Use: Many doctors prescribe diabetes versions (Ozempic, Mounjaro) off-label for weight loss because: Identical medication to weight loss versions Sometimes better insurance coverage Same effectiveness regardless of indication on label This is legal and common medical practice
Fact: Tirzepatide is equally effective regardless of when you last ate
Note: Ozempic and Rybelsus are not FDA-approved for treating obesity or weight loss
GLP-1 drugs have become widely used, but they have also been expensive and hard to afford, which is part of what these new programs aim to address
